Geode Capital Management
CRVO icon

Geode Capital Management’s CervoMed CRVO Stock Holding History

Geode Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
66,923
-7,448
-10% -$26.2K ﹤0.01% 3904
2026
Q1 		$293K Buy
74,371
+8,493
+13% +$44.4K ﹤0.01% 3788
2025
Q4 		$521K Buy
65,878
+1,411
+2% +$11.3K ﹤0.01% 3573
2025
Q3 		$522K Buy
64,467
+10,211
+19% +$87.6K ﹤0.01% 3600
2025
Q2 		$341K Sell
54,256
-62,225
-53% -$530K ﹤0.01% 3680
2025
Q1 		$1.07M Buy
116,481
+1,646
+1% +$6.27K ﹤0.01% 3285
2024
Q4 		$269K Sell
114,835
-99
-0.1% -$963 ﹤0.01% 3803
2024
Q3 		$1.68M Buy
114,934
+14,042
+14% +$218K ﹤0.01% 3183
2024
Q2 		$1.73M Buy
100,892
+79,717
+376% +$1.74M ﹤0.01% 3158
2024
Q1 		$494K Buy
21,175
+5,466
+35% +$72.9K ﹤0.01% 3620
2023
Q4 		$109K Buy
15,709
+4,617
+42% +$39.9K ﹤0.01% 4160
2023
Q3 		$52.9K Sell
11,092
-323
-3% -$1.63K ﹤0.01% 4406
2023
Q2 		$56.8K Hold
11,415
– – ﹤0.01% 4479
2023
Q1 		$71.2K Hold
11,415
– – ﹤0.01% 4439
2022
Q4 		$87K Sell
11,415
-28
-0.2% -$233 ﹤0.01% 4443
2022
Q3 		$91K Hold
11,443
– – ﹤0.01% 4609
2022
Q2 		$112K Sell
11,443
-2
-0% -$25 ﹤0.01% 4545
2022
Q1 		$214K Hold
11,445
– – ﹤0.01% 4344
2021
Q4 		$261K Hold
11,445
– – ﹤0.01% 4360
2021
Q3 		$437K Buy
11,445
+721
+7% +$30K ﹤0.01% 4095
2021
Q2 		$587K Buy
10,724
+1,390
+15% +$76.8K ﹤0.01% 3864
2021
Q1 		$642K Buy
9,334
+5,925
+174% +$497K ﹤0.01% 3724
2020
Q4 		$203K Hold
3,409
– – ﹤0.01% 3880
2020
Q3 		$215K Sell
3,409
-1,122
-25% -$85.3K ﹤0.01% 3695
2020
Q2 		$331K Buy
4,531
+2,208
+95% +$134K ﹤0.01% 3510
2020
Q1 		$55K Sell
2,323
-1,026
-31% -$31.1K ﹤0.01% 3907
2019
Q4 		$115K Buy
3,349
+3,215
+2,399% +$196K ﹤0.01% 3954
2019
Q3 		$18K Hold
134
– – ﹤0.01% 4153
2019
Q2 		$28K Hold
134
– – ﹤0.01% 4137
2019
Q1 		$37K Buy
+134
New +$32.2K ﹤0.01% 4053

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

Geode Capital Management's CRVO Position: Q2 2026 in Review

Geode Capital Management reduced its CervoMed (CRVO) stake by 10% in Q2 2026, selling an estimated $26.2K and leaving 66,923 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #3904.

Geode Capital Management first reported a position in CRVO in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.73M in Q2 2024. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Geode Capital Management held 66,923 shares of CervoMed worth $208K as of Q2 2026.
  • Geode Capital Management sold 7,448 CervoMed shares in Q2 2026, an estimated $26.2K.
  • CervoMed made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3904 holding.
  • Geode Capital Management first reported a position in CervoMed in Q1 2019 and has held it in 30 quarters since.
  • Geode Capital Management's CervoMed position peaked at $1.73M in Q2 2024.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.